HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Zhan Selected Research

valylvaline (Val-Val)

12/2013CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis.
10/2011CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
9/2010Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
7/2010MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Zhan Research Topics

Disease

43Neoplasms (Cancer)
03/2021 - 12/2002
35Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2009
27Lung Neoplasms (Lung Cancer)
03/2021 - 09/2009
20Neoplasm Metastasis (Metastasis)
08/2021 - 09/2009
10Adenocarcinoma of Lung
03/2021 - 04/2012
10Carcinogenesis
01/2018 - 09/2009
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2018 - 04/2012
7Breast Neoplasms (Breast Cancer)
02/2018 - 06/2010
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2021 - 07/2009
6Pleural Effusion (Pleural Effusions)
04/2020 - 07/2012
5Infections
06/2021 - 03/2011
4Inflammation (Inflammations)
01/2021 - 08/2016
3Ewing Sarcoma (Sarcoma, Ewing)
02/2021 - 03/2014
3Adenocarcinoma
01/2021 - 09/2009
3Carcinoma (Carcinomatosis)
01/2021 - 09/2009
3Hepatocellular Carcinoma (Hepatoma)
01/2020 - 06/2013
3Lymphatic Metastasis
01/2017 - 12/2012
3Stomach Neoplasms (Stomach Cancer)
01/2017 - 10/2012
3Malignant Pleural Effusion
05/2014 - 07/2012
3Prostatic Neoplasms (Prostate Cancer)
06/2013 - 12/2002
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2011
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 04/2018
2Lung Injury
01/2020 - 01/2019
2Ventilator-Induced Lung Injury
01/2020 - 10/2018
2Acute Lung Injury
01/2019 - 10/2018
2Pneumonia (Pneumonitis)
01/2019 - 12/2017
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2017 - 04/2016
2Osteolysis
02/2016 - 03/2009
2Pulmonary Tuberculosis
08/2013 - 12/2012
2Vomiting
02/2013 - 01/2013
2Hypertension (High Blood Pressure)
02/2013 - 01/2013
2Exanthema (Rash)
02/2013 - 01/2013
2Nausea
02/2013 - 01/2013
2Tuberculosis (Tuberculoses)
12/2012 - 07/2012
2Lung Diseases (Lung Disease)
05/2011 - 06/2010
1Obesity
02/2022
1Body Weight (Weight, Body)
02/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022
1Osteoporosis
11/2021
1Bone Resorption
11/2021

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
02/2021 - 06/2010
12Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2012
8Immune Checkpoint InhibitorsIBA
01/2022 - 12/2017
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2018 - 09/2009
6Messenger RNA (mRNA)IBA
10/2020 - 04/2012
6Small Interfering RNA (siRNA)IBA
10/2017 - 12/2013
5ErbB Receptors (EGF Receptor)IBA
08/2021 - 12/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 12/2002
5ORALIT (ORS)IBA
08/2019 - 06/2010
5Pharmaceutical PreparationsIBA
01/2019 - 12/2012
4CytokinesIBA
02/2022 - 07/2012
4Biological ProductsIBA
10/2020 - 08/2007
4valylvaline (Val-Val)IBA
12/2013 - 07/2010
3MicroRNAs (MicroRNA)IBA
08/2021 - 03/2014
3EnzymesIBA
05/2020 - 01/2014
3Cadherins (E-Cadherin)IBA
10/2019 - 10/2012
3Long Noncoding RNAIBA
04/2018 - 01/2014
3Interleukin-17 (Interleukin 17)IBA
02/2016 - 02/2014
3Indicators and Reagents (Reagents)IBA
08/2014 - 06/2012
2CreatinineIBA
01/2022 - 02/2021
2B7-H1 AntigenIBA
01/2022 - 08/2019
2Tumor Biomarkers (Tumor Markers)IBA
08/2021 - 01/2014
2Tyrosine Kinase InhibitorsIBA
08/2021 - 12/2015
2Carcinoembryonic AntigenIBA
08/2021 - 02/2014
2osimertinibIBA
08/2021 - 01/2019
2AlbuminsIBA
03/2021 - 02/2021
2Beclin-1IBA
02/2021 - 03/2018
2Oxidoreductases (Dehydrogenase)IBA
02/2021 - 06/2012
2fibrin fragment D (D-dimer)IBA
02/2021 - 02/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2016
2Itraconazole (Sporanox)FDA LinkGeneric
01/2021 - 12/2010
2Fluconazole (Zonal)FDA LinkGeneric
01/2021 - 12/2010
2Blood Glucose (Blood Sugar)IBA
05/2020 - 04/2018
2ImmunosorbentsIBA
01/2020 - 01/2014
2Farnesyltranstransferase (Farnesyltransferase)IBA
01/2020 - 01/2018
2Topotecan (Hycamtin)FDA LinkGeneric
12/2019 - 10/2018
2VimentinIBA
10/2019 - 01/2018
2Epidermal Growth Factor (EGF)IBA
10/2018 - 09/2018
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
02/2018 - 06/2012
2CateninsIBA
02/2017 - 01/2017
2LigandsIBA
08/2016 - 04/2015
2Estrogens (Estrogen)FDA Link
04/2016 - 02/2016
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
12/2013 - 10/2011
2isoleucylvalineIBA
12/2013 - 10/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2012 - 03/2011
2alanylalanine (Ala-Ala)IBA
09/2010 - 07/2010
1PolyphenolsIBA
02/2022
1Diphosphonates (Bisphosphonates)IBA
11/2021
1Actins (F Actin)IBA
11/2021
1MineralsIBA
11/2021
1Enoxacin (AT 2266)FDA Link
11/2021
1guanosine 5'-monophosphorothioateIBA
06/2021

Therapy/Procedure

19Drug Therapy (Chemotherapy)
01/2022 - 07/2009
16Therapeutics
01/2021 - 09/2011
5Immunotherapy
01/2021 - 08/2019
3Radiotherapy
02/2021 - 04/2015
2Transplantation
01/2019 - 08/2010
2Punctures
08/2013 - 12/2012
2Hematopoietic Stem Cell Transplantation
09/2011 - 07/2009